Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapySewanti Limaye, Barbara A. Murphy, Michael T. Brennan et al.|Cancer|2013Cited by 126